Received Dec 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | X7R4Z | — |
Menveo expired dose administration (more than 30 days difference between expiration and administration dates); This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number X7R4Z, expiry date 30-SEP-2025) for prophylaxis. On 26-NOV-2025, the patient received Menveo. On 26-NOV-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo expired dose administration (more than 30 days difference between expiration and administration dates)). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 01-DEC-2025 The vaccine administration facility was the same as primary reporter.